Visual acuity loss and clinical observations in a large series of patients with Stargardt disease.
about
The lipid translocase, ABCA4: seeing is believing.Stargardt disease: clinical features, molecular genetics, animal models and therapeutic optionsCone photoreceptor abnormalities correlate with vision loss in patients with Stargardt disease.Quantitative fundus autofluorescence in recessive Stargardt diseaseABCA4-associated retinal degenerations spare structure and function of the human parapapillary retina.Advances in imaging of Stargardt disease.In vivo visualization of photoreceptor layer and lipofuscin accumulation in stargardt's disease and fundus flavimaculatus by high resolution spectral-domain optical coherence tomography.Defective lipid transport and biosynthesis in recessive and dominant Stargardt macular degenerationAssociation of dark-adapted visual function with retinal structural changes in patients with Stargardt disease.Macular function and morphologic features in juvenile stargardt disease: longitudinal study.C20-D3-vitamin A slows lipofuscin accumulation and electrophysiological retinal degeneration in a mouse model of Stargardt disease.Near-infrared autofluorescence: its relationship to short-wavelength autofluorescence and optical coherence tomography in recessive stargardt diseaseClinical and molecular characteristics of childhood-onset Stargardt disease.Retinal cone and rod photoreceptor cells exhibit differential susceptibility to light-induced damageObjective Analysis of Hyperreflective Outer Retinal Bands Imaged by Optical Coherence Tomography in Patients With Stargardt DiseaseTreatment of Stargardt disease with dobesilate.Research resource: nuclear receptor atlas of human retinal pigment epithelial cells: potential relevance to age-related macular degenerationPredicting Progression of ABCA4-Associated Retinal Degenerations Based on Longitudinal Measurements of the Leading Disease Front.Correlation between photoreceptor layer integrity and visual function in patients with Stargardt disease: implications for gene therapy.Highly sensitive measurements of disease progression in rare disorders: Developing and validating a multimodal model of retinal degeneration in Stargardt diseaseCorrelating Photoreceptor Mosaic Structure to Clinical Findings in Stargardt Disease.Educational levels in patients with stargardt disease.En Face Spectral-Domain Optical Coherence Tomography for the Monitoring of Lesion Area Progression in Stargardt DiseaseCentrifugal expansion of fundus autofluorescence patterns in Stargardt disease over time.Peripapillary atrophy in Stargardt disease.A comparison of fundus autofluorescence and retinal structure in patients with Stargardt disease.Natural history of phenotypic changes in Stargardt macular dystrophy.Allelic and phenotypic heterogeneity in ABCA4 mutations.Juvenile-onset macular degeneration and allied disordersA Novel ABCA4 Mutation Associated with a Late-Onset Stargardt Disease Phenotype: A Hypomorphic Allele?Reading ability and quality of life in Stargardt disease.Novel therapeutics for Stargardt disease.Historical evolution in the understanding of Stargardt macular dystrophy.Morpho-functional correlation of fundus autofluorescence in Stargardt disease.Stargadt's disease in two Nigerian siblings.MAPPING THE DENSE SCOTOMA AND ITS ENLARGEMENT IN STARGARDT DISEASE.A Comparison of En Face Optical Coherence Tomography and Fundus Autofluorescence in Stargardt Disease.Predictors of visual acuity and genotype-phenotype correlates in a cohort of patients with Stargardt disease.Juvenile Macular Degenerations.Genotype-phenotype correlation in Italian families with Stargardt disease.
P2860
Q27693285-0960C10B-63DD-4D25-A58F-738CFA961257Q28075612-093E773A-B8C1-40DE-8703-80F84C185BE4Q30500872-1926721D-C251-4921-86E5-4C60F3167D66Q30577468-AD68A0B8-0097-46F8-B3BD-696EF33D0DACQ33227686-2D961D32-4220-40DA-A49E-A69433452E95Q33541901-55346805-9B9A-4F0D-A49E-01C749311340Q33571281-B2C07C75-9FE2-408C-BB3C-8D1EF77A4C2FQ34157723-DEA8C009-E091-4959-9AC8-63099FABDC57Q34274994-154DD7F4-4EB8-4BDE-A355-512D6CD7C771Q34615627-BD0DC0D7-24DB-45AF-9D4A-9047350AC343Q34624202-F2F49FEC-6801-4391-AE4C-7EC9700EEBC5Q35677324-6CF24099-B42B-4723-98F7-1566A3AAB880Q35694440-9372C7D3-20C3-428E-A019-8433F2E29DB7Q35830670-D6F4FAC1-C42B-4C48-9DC6-E8421979BCA8Q35891941-F5CDDCBB-9073-486A-A514-4D363C587095Q35979853-CB685E91-81E3-4192-AD50-B62D30BCF7E7Q36067442-A4CCED00-2950-4517-AEAA-98C6D15C4314Q36067981-E64E34D9-0337-4820-B5B9-10DCDC35A153Q36223792-73A946DA-978E-4FDE-B49D-E744BEB2EF4FQ36326882-3544DCA5-71C7-4237-86E2-3E1D394F31CDQ36683791-0E1E0B70-09B4-45AB-86DC-5A73F44C5596Q36968799-83B7A640-F8C2-42D6-A1E6-1354C295E556Q37143110-61556066-D81F-4442-8F52-1205C1F330D2Q37158866-80D535FA-D947-4F5F-B23B-59F7D287811FQ37346312-65B44E18-BAE6-4032-AC41-6D161A47F243Q37358982-1B50BF28-3892-42FC-B18E-4D7C9EAEB4DBQ37448421-5FC6DA92-A1BA-4DD8-81C4-E97D07DBB185Q37867686-CA51FA5C-3894-4697-B16C-972360227E45Q38204635-90633816-2C95-4EE5-B78B-7413D039BD63Q38671297-D7B1D3E6-8E58-490F-84C9-70B25A1560C7Q38826892-5E0E0405-09B3-4939-92C5-8CA134E70975Q39174655-C56A7329-9473-4D7F-B4D2-87C63C014F97Q39841882-C5A84F84-B1CD-41A9-8BCA-7D1715B7603DQ41120222-DC315337-7541-460B-A550-1A93CBF753B2Q41130648-1F202F95-D56A-4B5C-8390-5D6036FEA786Q41443342-0DE5B5BD-92F0-4769-A9BE-284BD527B84FQ42378291-FBF9F5E9-E139-408A-98E0-C215E9712C58Q44850776-F5787C05-7445-494B-828F-63ACF4AF3025Q45872357-18BD209B-65A4-4893-BF4E-3A2E63D19EEDQ46533698-87EE51DA-A611-4935-828A-F2B536FF60C2
P2860
Visual acuity loss and clinical observations in a large series of patients with Stargardt disease.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Visual acuity loss and clinica ...... tients with Stargardt disease.
@en
Visual acuity loss and clinica ...... tients with Stargardt disease.
@nl
type
label
Visual acuity loss and clinica ...... tients with Stargardt disease.
@en
Visual acuity loss and clinica ...... tients with Stargardt disease.
@nl
prefLabel
Visual acuity loss and clinica ...... tients with Stargardt disease.
@en
Visual acuity loss and clinica ...... tients with Stargardt disease.
@nl
P2093
P1433
P1476
Visual acuity loss and clinica ...... tients with Stargardt disease.
@en
P2093
Gerald A Fishman
Robert J Anderson
Ygal Rotenstreich
P304
P356
10.1016/S0161-6420(03)00333-6
P577
2003-06-01T00:00:00Z